AMYLOID
Clinical trials for AMYLOID explained in plain language.
Never miss a new study
Get alerted when new AMYLOID trials appear
Sign up with your email to follow new studies for AMYLOID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a new drug slow lewy body dementia? phase 2 trial begins
Disease control Recruiting nowThis phase 2 trial tests whether donanemab, an antibody given by IV, can slow worsening of thinking and daily function in people with early cognitive decline and Lewy body dementia. The study enrolls 350 participants who also have signs of two brain proteins (amyloid and alpha-sy…
Matched conditions: AMYLOID
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New PET tracer aims to spot hidden amyloid deposits
Diagnosis Recruiting nowThis study is testing a new imaging agent called [18F]FT8 to see if it can help doctors better see and diagnose amyloidosis, a disease where abnormal proteins build up in organs like the heart. The study will involve 20 patients with amyloidosis and 5 healthy volunteers. Research…
Matched conditions: AMYLOID
Sponsor: Tianjin Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Sleep hack may slow Alzheimer's: early study tests Time-in-Bed restriction
Knowledge-focused Recruiting nowThis study tests whether spending less time in bed for four weeks can deepen sleep and boost memory in adults aged 65-85 who have poor sleep and are at risk for Alzheimer's. Researchers will measure brain activity, memory, and blood markers. The goal is to see if a simple behavio…
Matched conditions: AMYLOID
Phase: EARLY_PHASE1 • Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC